CEO Steve Griffin outlined the company’s strategy, product portfolio, and growth priorities during a presentation at the Canaccord Genuity Musculoskeletal Conference, emphasizing a focus on top-line ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The U.S. Food and Drug Administration (FDA) has given ...
MONTREAL, May 16, 2024 /CNW/ - Pendopharm, a division of Pharmascience Canada ("Pendopharm"), is pleased to announce the renewal of its exclusive distribution agreement with Anika Therapeutics Inc ...
has launched ORTHOVISC(R) mini in the European Union. ORTHOVISC mini is a smaller dosage indication of ORTHOVISC(R), which has been marketed in Europe since 1996 and is used mainly for treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results